SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001387131-19-001535
Filing Date
2019-02-27
Accepted
2019-02-27 17:37:20
Documents
1
Period of Report
2019-02-26

Document Format Files

Seq Description Document Type Size
1 morris-form4_022719.html 4  
1 morris-form4_022719.xml 4 6307
  Complete submission text file 0001387131-19-001535.txt   7792
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Issuer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TONIX PHARMACEUTICALS HOLDING CORP 509 MADISON AVE., SUITE 306 NEW YORK NY 10022
Business Address
MORRIS JESSICA EDGAR (Reporting) CIK: 0001656531 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36019 | Film No.: 19639129